Skip to main content
Contact Us
Sign Up
Subscriber Sign In
navigation
サイト内検索
COVID-19
COVID-19 Update
Evaluate Vantage COVID-19 Report
COVID-19 Stories from Evaluate Vantage
Evaluate’s Business Continuity Plan
What We Do
Commercial Intelligence
Products
EvaluatePharma
Evaluate Omnium
Japan Drug Forecasts
European Drug Forecasts
Epi Analyzer
Evaluate Custom Solutions
Evaluate Vantage
News
Analysis
Policy & Pricing
Data Insights
Events
Medtech
Therapy Areas
Editorial Team
About Evaluate Vantage
How We Can Help You
Pharma and Biotech
Medtech
Financial Services
Management Consultancies
Service Providers
Customer Testimonials
Thought Leadership
About Us
Press Releases
Media Coverage
Executive Team
Vision & History
Careers
Current Vacancies
Contact Us
Sign Up for Evaluate Vantage
Subscriber Sign In
Search
Open configuration options
Search
Vantage
Covid-19
Covid-19 Coverage
Evaluate Vantage COVID-19 Report
News
Snippets
Deals
Trial results
Patents and litigation
Corporate strategy
Analysis
Interviews
Spotlight
Vantage points
Vantage views
Data Insights
M&A
IPO
NME approvals
Quarterly shareprice performance
Venture financing
Vantage data points
Other data
Events
Company events
Conferences
Upcoming events
Medtech
Therapy Areas
About
Editorial team
Epigenomics
April 26, 2017
Epigenomics goes private
February 27, 2017
Interview – Owlstone Medical hopes to breathe life into cancer diagnosis
July 13, 2016
FDA device approvals drop
April 13, 2016
FDA finds Epigenomics appealing
November 05, 2015
Epigenomics down but is it out?
October 07, 2015
Double whammy is Exactly the wrong prescription for Cologuard
August 12, 2014
Exact Sciences set for US reimbursement after Cologuard approved
July 10, 2014
Smaller companies swirl in the wake of medtech megamergers
April 14, 2014
As US adcoms fall, FDA free thinking rises
March 28, 2014
Colorectal screening set to become a slightly less inexact science
March 06, 2014
Event – Epigenomics and Exact await tough panel screening
Load More
We use cookies on this website. By using this site, you agree that we may store and access cookies on your device.
Find out more.
OK
Independent, data-driven daily news and analysis on pharma, biotech and medtech.
Sign up
Latest Reports
July 29, 2020
Evaluate Vantage Pharma, Biotech & Medtech Half-Year Review 2020
April 16, 2020
Evaluate Vantage COVID-19 Report
Editor's Picks
November 09, 2020
Pfizer and Biontech snatch first Covid vaccine victory
November 04, 2020
Scanning the horizon for future Covid-19 treatments
November 06, 2020
Ash 2020 preview – early winners and losers
November 05, 2020
Biogen’s aducanumab heads for US approval
October 26, 2020
Balancing the accuracy and cost of antigen testing
